Critical Functions of the Lysosome in Cancer Biology.
暂无分享,去创建一个
[1] A. Kariminia,et al. Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] M. Jäättelä,et al. Lysosomal involvement in cell death and cancer. , 2009, Biochimica et biophysica acta.
[3] Yu Zhao,et al. Synthesis and Evaluation of Cleistanthin A Derivatives as Potent Vacuolar H+‐ATPase Inhibitors , 2015, Chemical biology & drug design.
[4] Gregory A. Wyant,et al. The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway , 2016, Cell.
[5] S. Avnet,et al. Impairment of Lysosomal Activity as a Therapeutic Modality Targeting Cancer Stem Cells of Embryonal Rhabdomyosarcoma Cell Line RD , 2014, PloS one.
[6] D. Gottschling,et al. An Early-Age Increase in Vacuolar pH Limits Mitochondrial Function and Lifespan in Yeast , 2012, Nature.
[7] R. Abraham,et al. The PI3K, metabolic, and autophagy networks: interactive partners in cellular health and disease. , 2013, Annual review of pharmacology and toxicology.
[8] D. Hoepfner,et al. The Marine Natural Product Manzamine A Targets Vacuolar ATPases and Inhibits Autophagy in Pancreatic Cancer Cells , 2013, Marine drugs.
[9] M. Serrano,et al. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. , 2007, Genes & development.
[10] B. Levine,et al. Autosis and autophagic cell death: the dark side of autophagy , 2014, Cell Death and Differentiation.
[11] Kailiang Jia,et al. Autophagy genes function in apoptotic cell corpse clearance during C. elegans embryonic development , 2013, Autophagy.
[12] Xiaopei Huang,et al. Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation. , 2015, The Journal of clinical investigation.
[13] E. Kassi,et al. Glucocorticoid receptor signaling and prostate cancer. , 2011, Cancer letters.
[14] P. Codogno,et al. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line , 1997, Cell and Tissue Research.
[15] R. Halaby. Role of lysosomes in cancer therapy , 2015 .
[16] N. Demartines,et al. Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives , 2011, Cancers.
[17] D. Sabatini,et al. Identification of an oncogenic RAB protein , 2015, Science.
[18] M. Jäättelä,et al. Cancer-associated lysosomal changes: friends or foes? , 2013, Oncogene.
[19] N. Hacohen,et al. Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy. , 2014, Cell reports.
[20] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[21] C. Thompson,et al. At the Bench: Preclinical rationale for CTLA‐4 and PD‐1 blockade as cancer immunotherapy , 2013, Journal of leukocyte biology.
[22] Yang Li,et al. A nanobuffer reporter library for fine-scale imaging and perturbation of endocytic organelles , 2015, Nature Communications.
[23] P. Frankel,et al. Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel Formation , 2014, Cells.
[24] Gerald C. Chu,et al. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. , 2014, Cancer discovery.
[25] R. Lewensohn,et al. Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer , 2014, Cell Death and Disease.
[26] A. Cuervo,et al. Chaperone-mediated autophagy: roles in disease and aging , 2013, Cell Research.
[27] Robin Mathew,et al. Role of autophagy in cancer , 2007, Nature Reviews Cancer.
[28] Shizuo Akira,et al. Regulation of innate immune responses by autophagy-related proteins , 2010, The Journal of cell biology.
[29] W. Schiemann,et al. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. , 2004, Molecular cancer research : MCR.
[30] D. Ruggero,et al. Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer , 2014, Cell.
[31] A. Amon,et al. Short- and long-term effects of chromosome mis-segregation and aneuploidy , 2015, Nature Reviews Molecular Cell Biology.
[32] K. Ryan,et al. Loss of autophagy causes a synthetic lethal deficiency in DNA repair , 2015, Proceedings of the National Academy of Sciences.
[33] K. Taylor,et al. Disulfiram-induced cytotoxicity and endo-lysosomal sequestration of zinc in breast cancer cells , 2015, Biochemical Pharmacology.
[34] T. Walther,et al. The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis , 2012, Science Signaling.
[35] U. Brunk,et al. Lysosomes in iron metabolism, ageing and apoptosis , 2008, Histochemistry and Cell Biology.
[36] Ira Mellman,et al. Endocytosis and cancer. , 2013, Cold Spring Harbor perspectives in biology.
[37] C. Münz. Antigen processing via autophagy--not only for MHC class II presentation anymore? , 2010, Current opinion in immunology.
[38] L. Cantley,et al. Regulation of mTORC1 by PI3K signaling. , 2015, Trends in cell biology.
[39] P. Saftig,et al. Lysosomal membrane proteins: life between acid and neutral conditions. , 2010, Biochemical Society transactions.
[40] S. Manalis,et al. Biophysical changes reduce energetic demand in growth factor–deprived lymphocytes , 2016, The Journal of cell biology.
[41] I. Ellis,et al. Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer , 2015, Breast Cancer Research and Treatment.
[42] J. Clohessy,et al. Pro-senescence therapy for cancer treatment , 2011, Nature Reviews Cancer.
[43] M. Jäättelä,et al. Combating apoptosis and multidrug resistant cancers by targeting lysosomes. , 2013, Cancer letters.
[44] H. Padh,et al. Organelle targeting: third level of drug targeting , 2013, Drug design, development and therapy.
[45] J. Goldenring. A central role for vesicle trafficking in epithelial neoplasia: intracellular highways to carcinogenesis , 2013, Nature Reviews Cancer.
[46] S. Terai,et al. Deferoxamine for advanced hepatocellular carcinoma. , 2011, The New England journal of medicine.
[47] S. Kornfeld. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. , 1992, Annual review of biochemistry.
[48] F. López‐Soriano,et al. Cancer cachexia: understanding the molecular basis , 2014, Nature Reviews Cancer.
[49] D. Guertin,et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.
[50] A. Sorkin,et al. Endocytosis of receptor tyrosine kinases. , 2013, Cold Spring Harbor perspectives in biology.
[51] B. Turk,et al. The endolysosomal system in cell death and survival. , 2013, Cold Spring Harbor perspectives in biology.
[52] J. Geng,et al. IGF2R Expression is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC , 2014, Cellular Physiology and Biochemistry.
[53] P. Gleeson,et al. Macropinocytosis: an endocytic pathway for internalising large gulps , 2011, Immunology and cell biology.
[54] Andrea Ballabio,et al. Signals from the lysosome: a control centre for cellular clearance and energy metabolism , 2013, Nature Reviews Molecular Cell Biology.
[55] K. Ross,et al. Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism , 2015, Nature.
[56] Guido Kroemer,et al. Autophagy in the Pathogenesis of Disease , 2008, Cell.
[57] S. Conzen,et al. Targeting the glucocorticoid receptor in breast and prostate cancers , 2015, Science Translational Medicine.
[58] J. Luzio,et al. Membrane dynamics and the biogenesis of lysosomes (Review) , 2003 .
[59] E. White,et al. Role of autophagy in suppression of inflammation and cancer. , 2010, Current opinion in cell biology.
[60] N. Grishin,et al. EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance , 2013, Cell.
[61] D. Peeper,et al. The essence of senescence. , 2010, Genes & development.
[62] J. Winkler,et al. Lys05 , 2012, Autophagy.
[63] Andrea Ballabio,et al. TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.
[64] F. Zunino,et al. SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis , 2011, Clinical Cancer Research.
[65] M. V. Vander Heiden,et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. , 2015, Cancer research.
[66] M. Zerial,et al. Macropinocytosis of the PDGF β-receptor promotes fibroblast transformation by H-RasG12V , 2012, Molecular biology of the cell.
[67] H. Hirano,et al. Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus , 2015, Nature.
[68] J. Chien,et al. PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples. , 2015, European journal of cancer.
[69] M. R. Lamprecht,et al. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.
[70] R. Deberardinis,et al. Metabolic pathways promoting cancer cell survival and growth , 2015, Nature Cell Biology.
[71] Takeshi Tokuhisa,et al. The role of autophagy during the early neonatal starvation period , 2004, Nature.
[72] A. Mancuso,et al. Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress. , 2013, Genes & development.
[73] S. Akira,et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages , 2009, Nature Cell Biology.
[74] E. White,et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids , 2013, Proceedings of the National Academy of Sciences.
[75] P. Klenerman,et al. Autophagy is a critical regulator of memory CD8+ T cell formation , 2014, eLife.
[76] E. White,et al. Autophagy suppresses tumor progression by limiting chromosomal instability. , 2007, Genes & development.
[77] William A. Gahl,et al. Cysteamine Suppresses Invasion, Metastasis and Prolongs Survival by Inhibiting Matrix Metalloproteinases in a Mouse Model of Human Pancreatic Cancer , 2012, PloS one.
[78] J. Bonifacino,et al. Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 γ–σ1 and AP-3 δ–σ3 hemicomplexes , 2003, The Journal of cell biology.
[79] L. Galluzzi,et al. Chloroquine and hydroxychloroquine for cancer therapy , 2014, Molecular & cellular oncology.
[80] Christian M. Metallo,et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.
[81] C. L. Chu,et al. M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis , 2011, PloS one.
[82] B. Turk. Targeting proteases: successes, failures and future prospects , 2006, Nature Reviews Drug Discovery.
[83] Rugang Zhang,et al. Nucleotide metabolism, oncogene-induced senescence and cancer. , 2015, Cancer letters.
[84] J. Campisi,et al. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.
[85] S. Cohen,et al. Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor , 1979, The Journal of cell biology.
[86] M. Bisoffi,et al. Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate‐specific antigen expression and secretion , 2013, International journal of cancer.
[87] K. Ryan,et al. Autophagy and cancer. , 2012, Cold Spring Harbor perspectives in biology.
[88] Valerio Embrione,et al. A Gene Network Regulating Lysosomal Biogenesis and Function , 2009, Science.
[89] H. Algül,et al. Risk Factors and Therapeutic Targets in Pancreatic Cancer , 2013, Front. Oncol..
[90] M. Raff,et al. Size Control: The Regulation of Cell Numbers in Animal Development , 1996, Cell.
[91] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.
[92] D. Tuveson,et al. The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1 , 2015, Cell.
[93] Gordon B. Mills,et al. Derailed endocytosis: an emerging feature of cancer , 2008, Nature Reviews Cancer.
[94] R. Youle,et al. Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.
[95] I. Vlodavsky,et al. The heparanase system and tumor metastasis: is heparanase the seed and soil? , 2011, Cancer and Metastasis Reviews.
[96] A. Schulze,et al. Linking glycogen and senescence in cancer cells. , 2012, Cell metabolism.
[97] M. Kirby,et al. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. , 2009, Clinical science.
[98] L. Walker,et al. Confusing signals: Recent progress in CTLA-4 biology , 2015, Trends in immunology.
[99] P. A. Pérez-Mancera,et al. Inside and out: the activities of senescence in cancer , 2014, Nature Reviews Cancer.
[100] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[101] Jon J Briggs,et al. Cystatin E/M suppresses legumain activity and invasion of human melanoma , 2010, BMC Cancer.
[102] D. Bar-Sagi,et al. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. , 1986, Science.
[103] C. Pethiyagoda,et al. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells , 2004, Clinical & Experimental Metastasis.
[104] S. Turner,et al. Jailbreak: oncogene-induced senescence and its evasion. , 2011, Cellular signalling.
[105] Peter Kraft,et al. Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development , 2014, Nature Medicine.
[106] Marc Liesa,et al. Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.
[107] M. Matsuda,et al. Syndecan 4 Regulates FGFR1 Signaling in Endothelial Cells by Directing Macropinocytosis , 2012, Science Signaling.
[108] H. Lien,et al. Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity. , 2006, Lung cancer.
[109] E. White,et al. A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62 , 2010, Molecular and Cellular Biology.
[110] S. Ang,et al. The role of secretory and endocytic pathways in the maintenance of cell polarity. , 2012, Essays in biochemistry.
[111] D. Finkelstein,et al. Regulated lysosomal exocytosis mediates cancer progression , 2015, Science Advances.
[112] Toshihiko Kobayashi,et al. How do cells optimize luminal environments of endosomes/lysosomes for efficient inflammatory responses? , 2013, Journal of biochemistry.
[113] P. Carmeliet. Angiogenesis in health and disease , 2003, Nature Medicine.
[114] Bonnie F. Sloane,et al. Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.
[115] B. Henderson,et al. IGF2R Missense Single-Nucleotide Polymorphisms and Breast Cancer Risk: The Multiethnic Cohort Study , 2009, Cancer Epidemiology Biomarkers & Prevention.
[116] M. Washington,et al. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. , 1995, Oncogene.
[117] M. Hengartner. Apoptosis Corralling the Corpses , 2001, Cell.
[118] K. Okumura,et al. Cathepsin K-mediated notch1 activation contributes to neovascularization in response to hypoxia , 2014, Nature Communications.
[119] M. Montgomery,et al. Dominant‐negative effect of truncated mannose 6‐phosphate/insulin‐like growth factor II receptor species in cancer , 2012, The FEBS journal.
[120] E. Im,et al. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. , 2005, Molecular biology of the cell.
[121] S. Manalis,et al. Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells. , 2016, Developmental cell.
[122] William J. Israelsen,et al. Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. , 2014, Molecular cell.
[123] J. Lippincott-Schwartz,et al. Role of Grb2 in EGF-stimulated EGFR internalization. , 2002, Journal of cell science.
[124] J. Taub,et al. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. , 2014, Cellular signalling.
[125] Peter D. Adams,et al. Lysosome-mediated processing of chromatin in senescence , 2013, The Journal of cell biology.
[126] D. Hanahan,et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.
[127] Matthew G. Vander Heiden,et al. Exploiting tumor metabolism: challenges for clinical translation , 2013 .
[128] Seamus J. Martin,et al. Autophagy in malignant transformation and cancer progression , 2015, The EMBO journal.
[129] J. Falls,et al. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors , 1998, Oncogene.
[130] I. Katona,et al. Regulation of endoplasmic reticulum turnover by selective autophagy , 2015, Nature.
[131] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[132] E. White,et al. Role of Autophagy in Cancer Prevention , 2011, Cancer Prevention Research.
[133] A. Kimmelman,et al. The dynamic nature of autophagy in cancer. , 2011, Genes & development.
[134] K. Anderson,et al. Regulated nuclear import of Rel proteins in the Drosophila immune response , 1998, Nature.
[135] D. Klionsky,et al. The machinery of macroautophagy , 2013, Cell Research.
[136] D. DiMaio,et al. Senescence‐associated β‐galactosidase is lysosomal β‐galactosidase , 2006 .
[137] A. Ballabio,et al. Lysosome: regulator of lipid degradation pathways , 2014, Trends in cell biology.
[138] Y. Assaraf,et al. Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers , 2012, Cell Death and Disease.
[139] Shengbing Huang,et al. The Role of Autophagy in Cancer: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.
[140] L. Holsinger,et al. Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. , 2010, Biochimie.
[141] Liang Liu,et al. Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells , 2014, Scientific Reports.
[142] A. Brech,et al. Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes. , 2003, The Biochemical journal.
[143] A. Ullrich,et al. The discovery of receptor tyrosine kinases: targets for cancer therapy , 2004, Nature Reviews Cancer.
[144] Jae U. Jung,et al. Autophagy genes as tumor suppressors. , 2010, Current opinion in cell biology.
[145] Sophie Dahan,et al. Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction. , 2016, Annual review of biochemistry.
[146] A. Houghton,et al. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells , 2004, International journal of cancer.
[147] J. Debnath,et al. Autophagy and cancer metabolism. , 2014, Methods in enzymology.
[148] Hongbin Ji,et al. Regulation of EGFR nanocluster formation by ionic protein-lipid interaction , 2014, Cell Research.
[149] Xiaonan Dong,et al. Fanconi Anemia Proteins Function in Mitophagy and Immunity , 2016, Cell.
[150] Chi Li,et al. Growth Factor Regulation of Autophagy and Cell Survival in the Absence of Apoptosis , 2005, Cell.
[151] Lewis A. Chodosh,et al. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis , 2007, Nature Cell Biology.
[152] T. Irimura,et al. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. , 1984, The Journal of biological chemistry.
[153] M. Barbacid,et al. Tumour biology: Senescence in premalignant tumours , 2005, Nature.
[154] J. Campisi,et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[155] K. Ye,et al. Proteinase 3-dependent caspase-3 cleavage modulates neutrophil death and inflammation. , 2014, The Journal of clinical investigation.
[156] A. Malmström,et al. TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated , 2011, Journal of Translational Medicine.
[157] Z. Wang,et al. PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection , 2016, Tumor Biology.
[158] C. Johannessen,et al. A negative feedback signaling network underlies oncogene-induced senescence. , 2006, Cancer cell.
[159] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[160] J. Westermarck,et al. Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[161] Matthew P. Jacobson,et al. Dysregulated pH: a perfect storm for cancer progression , 2011, Nature Reviews Cancer.
[162] D. Sabatini,et al. Nutrient-sensing mechanisms and pathways , 2015, Nature.
[163] S. Ryter,et al. Autophagy in Inflammatory Diseases , 2011, International journal of cell biology.
[164] R. Amaravadi,et al. Targeting the lysosome in cancer , 2016, Annals of the New York Academy of Sciences.
[165] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[166] J. Garin,et al. An Extended Proteome Map of the Lysosomal Membrane Reveals Novel Potential Transporters* , 2013, Molecular & Cellular Proteomics.
[167] K. Macleod,et al. Mitophagy and cancer , 2015, Cancer & Metabolism.
[168] John M. Asara,et al. Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.
[169] L. P. Van den Heuvel,et al. Cysteamine: an old drug with new potential. , 2013, Drug discovery today.
[170] C. Heldin,et al. Suppressors of T-cell Receptor Signaling Sts-1 and Sts-2 Bind to Cbl and Inhibit Endocytosis of Receptor Tyrosine Kinases* , 2004, Journal of Biological Chemistry.
[171] D. Hanahan,et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.
[172] A. Ballabio,et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB , 2012, The EMBO journal.
[173] A. Amon,et al. Aneuploidy triggers a TFEB-mediated lysosomal stress response , 2015, Autophagy.
[174] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[175] M. Jäättelä,et al. Lysosomal cell death at a glance , 2013, Journal of Cell Science.
[176] M. Lyon,et al. The Interaction of the Transforming Growth Factor-βs with Heparin/Heparan Sulfate Is Isoform-specific* , 1997, The Journal of Biological Chemistry.
[177] P. Hines. A Tale of Two Stomata , 2011, Science Signaling.
[178] D. Sabatini,et al. Sestrin2 is a leucine sensor for the mTORC1 pathway , 2016, Science.
[179] C. Gey,et al. Metabolic changes during cellular senescence investigated by proton NMR-spectroscopy , 2013, Mechanisms of Ageing and Development.
[180] G. Kroemer,et al. Lysosomal membrane permeabilization in cell death , 2008, Oncogene.
[181] D. Kurz,et al. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. , 2000, Journal of cell science.
[182] H. Stein,et al. Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.
[183] G. Superti-Furga,et al. SLC38A9 is a component of the lysosomal amino acid-sensing machinery that controls mTORC1 , 2014, Nature.
[184] M. Washington,et al. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity , 1995, Nature Genetics.
[185] W. Razaq. Bone Targeted Therapies for Bone Metastasis in Breast Cancer , 2013, Journal of clinical medicine.
[186] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[187] Michael D. Schneider,et al. Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.
[188] Amy Y. M. Au,et al. p53 status determines the role of autophagy in pancreatic tumour development , 2013, Nature.
[189] E. White. Role of autophagy in cancer , 2012 .
[190] L. Chiarelli,et al. Expanding Targets for a Metabolic Therapy of Cancer: L-Asparaginase , 2012 .
[191] K. Lidke,et al. The spatiotemporal organization of ErbB receptors: insights from microscopy. , 2014, Cold Spring Harbor perspectives in biology.
[192] T. Hsia,et al. Novel quinolone CHM‐1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[193] S. Sarkar,et al. Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor. , 2012, Anticancer research.
[194] E. White,et al. Aneuploidy-induced cellular stresses limit autophagic degradation , 2015, Genes & development.
[195] E. Mckenzie,et al. Heparanase: a target for drug discovery in cancer and inflammation , 2007, British journal of pharmacology.
[196] M. Corrotte,et al. Damage control: cellular mechanisms of plasma membrane repair. , 2014, Trends in cell biology.
[197] S. Mitani,et al. Negative regulation of phosphatidylinositol 3-phosphate levels in early-to-late endosome conversion , 2016, The Journal of cell biology.
[198] T. Jacks,et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. , 2013, Genes & development.
[199] H. Hibshoosh,et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.
[200] U. Felbor,et al. Sensitization to the Lysosomal Cell Death Pathway upon Immortalization and Transformation , 2004, Cancer Research.
[201] T. Gonda,et al. PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models , 2011, British Journal of Cancer.
[202] K. Hahn,et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling , 2010, The Journal of cell biology.
[203] Yoshito Yamada,et al. Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice , 2015, Clinical & Experimental Metastasis.
[204] Nektarios Tavernarakis,et al. A dual role of p53 in the control of autophagy , 2008, Autophagy.
[205] B. Lindkvist,et al. Cathepsin B Activates Human Trypsinogen 1 but Not Proelastase 2 or Procarboxypeptidase B , 2006, Pancreatology.
[206] K. Ravichandran,et al. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. , 2013, Cold Spring Harbor perspectives in biology.
[207] Guido Kroemer,et al. Lysosomes and autophagy in cell death control , 2005, Nature Reviews Cancer.
[208] G. Peters,et al. Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance , 2011, Clinical Cancer Research.
[209] J. Beaulieu,et al. Loss of cathepsin L activity promotes claudin‐1 overexpression and intestinal neoplasia , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.